Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piracetam as Adherence Marker in Healthy Volunteers
NCT05918341Phase 4Unknown
- Sponsor
- Netherlands Cancer Institute
- Start
- Jul 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of piracetam in cocaine use disorder (CUD) and opioid use disorder (OUD), sponsored by Netherlands Cancer Institute. Primary endpoint: Detectability of piracetam in urine. Status: unknown.
02
Drugs
piracetam
03
Conditions
cocaine use disorder (CUD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05918341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05918341.